19 research outputs found

    Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Recent developments in radiotherapeutic technology have resulted in a new approach to treating patients with localized lung cancer. We report preliminary clinical outcomes using stereotactic radiosurgery with real-time tumor motion tracking to treat small peripheral lung tumors.</p> <p>Methods</p> <p>Eligible patients were treated over a 24-month period and followed for a minimum of 6 months. Fiducials (3–5) were placed in or near tumors under CT-guidance. Non-isocentric treatment plans with 5-mm margins were generated. Patients received 45–60 Gy in 3 equal fractions delivered in less than 2 weeks. CT imaging and routine pulmonary function tests were completed at 3, 6, 12, 18, 24 and 30 months.</p> <p>Results</p> <p>Twenty-four consecutive patients were treated, 15 with stage I lung cancer and 9 with single lung metastases. Pneumothorax was a complication of fiducial placement in 7 patients, requiring tube thoracostomy in 4. All patients completed radiation treatment with minimal discomfort, few acute side effects and no procedure-related mortalities. Following treatment transient chest wall discomfort, typically lasting several weeks, developed in 7 of 11 patients with lesions within 5 mm of the pleura. Grade III pneumonitis was seen in 2 patients, one with prior conventional thoracic irradiation and the other treated with concurrent Gefitinib. A small statistically significant decline in the mean % predicted DLCO was observed at 6 and 12 months. All tumors responded to treatment at 3 months and local failure was seen in only 2 single metastases. There have been no regional lymph node recurrences. At a median follow-up of 12 months, the crude survival rate is 83%, with 3 deaths due to co-morbidities and 1 secondary to metastatic disease.</p> <p>Conclusion</p> <p>Radical stereotactic radiosurgery with real-time tumor motion tracking is a promising well-tolerated treatment option for small peripheral lung tumors.</p

    ECCM15 -15 PREPARATION AND CHARACTERIZATION OF POLY(ETHYLENE OXIDE)/LITHIUM MONTMORILLONITE COMPOSITES

    No full text
    Abstract Poly(ethylene oxide)/lithium montmorillonite (PEO/LiMMT) composites were prepared by mixing and ultrasonication PEO and LiMMT in water. Characterization of PEO/LiMMT composites was performed by differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FT-IR) and non-isothermal thermogravimetry (TGA). DSC and TGA reveal that higher loadings of LiMMT significantly influence the crystallinity, melting temperatures and thermal stability of PEO, respectively. Glass transition temperatures of PEO do not change with addition of LiMMT. FT-IR analysis shows that the helical structure of PEO chains is distorted in PEO/LiMMT composites. Changes of activation energy in composites compared to pure PEO indicate possible changes in the mechanism of the nonisothermal degradation of PEO due to addition of LiMMT. Introduction Poly(ethylene oxide) (PEO) as solid polymer electrolyte in lithium polymer batteries has many advantages over its liquid counterparts or organic solutions due to the ease of processing, stable electrochemical characteristics and excellent mechanical propertie
    corecore